scholarly journals Evaluation of endothelial dysfunction and the possibility of its correction at the present stage in patients with cardiovascular diseases

Kardiologiia ◽  
2019 ◽  
Vol 59 (3S) ◽  
pp. 4-9 ◽  
Author(s):  
M. O. Samolyuk ◽  
N. Yu. Grigorieva
Keyword(s):  
Quality Of Life ◽  
Nitric Oxide ◽  
Cardiovascular Diseases ◽  
Endothelial Dysfunction ◽  
Mortality Rates ◽  
Present Stage ◽  
Advantages And Disadvantages ◽  
Complications And Mortality

The review describes the current understanding of endothelial dysfunction, methods of its evaluation, and highlights the advantages and disadvantages of various techniques. The role of nitric oxide and endothelin as important markers of endothelial dysfunction is shown, and the methods of their determination in clinical practice are described. The authors conclude that in order to improve the life expectancy and quality of life of patients with cardiovascular diseases, reduce the risk and frequency of complications and mortality rates, it is necessary to study the function of endothelium in more detail and to look for ways of drug correction, taking into account the pathogenetic mechanisms of its formation. 

scholarly journals The role of nitric oxide in improving endothelial function andcardiovascular health: focus on nebivolol

2011 ◽  
Vol 10 (2) ◽  
pp. 116-121
Author(s):  
G. L. Bakris ◽  
J. N. Basile ◽  
T. D. Giles ◽  
A. A. Taylor
Keyword(s):  
Quality Of Life ◽  
Nitric Oxide ◽  
Antihypertensive Agents ◽  
Clinical Implications ◽  
Cvd Risk ◽  
Patients With Diabetes ◽  
Β Blocker ◽  
Β Blockers

Although β-blockers have been endorsed by guidelines committees for the treatment of patients with hypertension, particularly those with significant CVD and high CVD risk, there are concerns about conventional β-blockers related to poorer clinical outcomes compared with other classes of antihypertensive agents, as well as deleterious effects on quality of life and lipid and carbohydrate metabolism. β-blockers comprise a heterogeneous group of antihypertensive agents, including nonselective agents, cardioselective, nonvasodilating agents, and vasodilating agents that either combine β-nonselectivity with β-blockade or possess cardioselectivity without β-blockade. The pharmacologic, mechanistic, and hemodynamic differences between conventional, nonvasodilating β-blockers and vasodilating β-blockers are discussed in this review, with a focus on the cardioselective vasodilating β-blocker nebivolol. These differences may have important clinical implications, particularly in the treatment of complicated hypertension, such as that associated with patients with diabetes or cardiometabolic syndrome, elderly patients, and African American patients, suggesting that mechanism of action may be an important consideration when choosing a β-blocker.

Role of Ethnicity on Pain Perception, Fatigue, and Quality of Life in a Pediatric Chronic Pain Population

2007 ◽  
Author(s):  
Jeffrey I. Gold ◽  
Trina Haselrig ◽  
D. Colette Nicolaou ◽  
Katharine A. Belmont
Keyword(s):  
Quality Of Life ◽  
Chronic Pain ◽  
Pain Perception ◽  
Pediatric Chronic Pain

Self-efficacy and quality of life among people with cardiovascular diseases: A meta-analysis.

2018 ◽  
Vol 63 (2) ◽  
pp. 295-312 ◽  
Author(s):  
Anna Banik ◽  
Ralf Schwarzer ◽  
Nina Knoll ◽  
Katarzyna Czekierda ◽  
Aleksandra Luszczynska
Keyword(s):  
Quality Of Life ◽  
Cardiovascular Diseases ◽  
Self Efficacy ◽  
Meta Analysis
Sign in / Sign up

Export Citation Format

Share Document